close_game
close_game
[

covishield news

]

Latest from covishield

How dangerous is FLiRT? 5 things about new Covid-19 variant spreading in US

In the wake of waning immunity and social distancing no longer a norm, it's important to stay alert against the new Covid threat. Here're key facts about FLiRT.

In the landscape of Covid-19, Covid-19 variants within the Omicron JN.1 lineage, called FLiRt variants, present new challenges. The variants KP.2 and KP 1.1 have new mutations (Freepik)
Published on May 10, 2024 01:29 PM IST
By, New Delhi

Covishield side effects: Doctors' group urges govt to review all Covid vaccines

At a press conference, the doctors, under the banner of the Awaken India Movement (AIM), urged the government to review the science behind all Covid vaccines.

When the COVID-19 vaccines were being administered, not many people were aware that it was being done without the completion of phase-3 trials. (FILE PHOTO)(HT_PRINT)
Published on May 10, 2024 11:32 AM IST
PTI | | Posted by Parmita Uniyal, New Delhi

Covishield rolled back; should those jabbed with it need to worry?

After AstraZeneca withdraws Covishield, should those who took the vaccine be worried about its potential side effects on health? We asked a few experts.

Updated on May 10, 2024 11:27 AM IST
By, New Delhi

All Covishield side-effects were disclosed: Serum Institute of India

Emphasizing safety as a priority, the company also highlighted Covishield’s role in saving millions of lives globally.

The pharma giant has begun the worldwide withdrawal of its Covid-19 vaccine due to a ‘surplus of available updated vaccines’ that target new variants of the virus. (FILE PHOTO)
Updated on May 09, 2024 04:10 AM IST
ByVicky Pathare

‘Disclosed all rare side effects’: SII clarifies amid vaccine safety row

In India, the Serum Institute of India (SII) said it stopped the manufacturing of additional doses of Covishield since December 2021.

A vial of the Covishield vaccine. (HT File Photo)
Published on May 08, 2024 07:55 PM IST

Stopped manufacturing Covishield since December 2021, says Serum Institute

The Serum Institute of India said with India achieving high vaccination rates in 2021 and 2022, coupled with the emergence of new mutant variant strains, the demand for previous vaccines diminished significantly

The Serum Institute of India building at Hadapsar, Pune. (Rahul Raut/HT PHOTO)
Updated on May 08, 2024 06:47 PM IST

AstraZeneca to withdraw Covid vaccine worldwide amid safety issues: Report

AstraZeneca states the move is due to a “surplus of available updated vaccines” since the Covid-19 pandemic.

Amid safety concerns, AstraZeneca withdraws Covid vaccine worldwide: Report(REUTERS/File photo )
Updated on May 08, 2024 08:18 AM IST
Written by Manjiri Chitre | Edited by

Afternoon briefing: Delhi Police's ‘fake msgs’ warning

The shortlist of biggest headlines, recommended stories, and special collection of news items you should check out.

Delhi school bomb threat news: Police and fire department personnel outside Mother Mary's School at Mayur Vihar, in New Delhi on Wednesday( (PTI Photo/Ravi Choudhary) )
Published on May 02, 2024 01:25 PM IST

Parents sue Serum Institute over daughter's death, allegedly due to Covishield

Covishield is the Indian variant of AstraZeneca's Covid-19 vaccine. AstraZeneca recently admitted that its vaccine can cause a rare side-effect called ‘TTS.’

AstraZeneca has said that due to the same vaccine, blood clotting takes place and it can lead to a lowered platelete count. (Reuters/File)
Published on May 02, 2024 11:19 AM IST
By, New Delhi

Lawyer files plea in SC for probe into side effects of Covishield

The plea said a medical expert panel be constituted under the supervision of a former Supreme Court judge to look into the matter

AstraZeneca has said Covishield can cause Thrombosis Thrombocytopenia Syndrome. (REUTERS)
Published on May 01, 2024 03:52 PM IST
ByAbraham Thomas

'Bigger crime than violating MCC': Akhilesh Yadav on Covishield row

AstraZeneca recently admitted that its Covid vaccines ‘Covishield’ and ‘Vaxzevria’ can, in very rare cases, cause Thrombosis Thrombocytopenia Syndrome (TTS).

Samajwadi Party chief Akhilesh Yadav (HT file)(HT_PRINT)
Published on May 01, 2024 03:22 PM IST

Fact Check: Are Covishield-vaccinated Indians susceptible to developing TTS?

AstraZeneca accepted in a legal submission that their Covid vaccine Covishield can cause Thrombosis with Thrombocytopenia Syndrome.

Covishield, AstraZeneca's Indian version of the Covid vaccine, in the country. (File image)
Updated on May 01, 2024 11:39 AM IST

Experts brush off concerns over Covid jab’s side effects

The AstraZeneca vaccine Vaxzevria was administered in India under the brand name Covishield and manufactured by the Serum Institute of India (SII)

AstraZeneca is fighting a class action lawsuit seeking damages worth nearly 100 million British pounds, according to local media reports (REUTERS)
Updated on May 01, 2024 05:56 AM IST
By, New Delhi

Covishield's rare side effect: What is Thrombosis Thrombocytopenia Syndrome?

AstraZeneca (AZ) has admitted its Covid vaccine may cause Thrombosis with Thrombocytopenia Syndrome (TTS). Know all about the rare side effect.

“It is admitted that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is not known,
Published on Apr 30, 2024 06:17 PM IST
By, New Delhi

First ever comparative study reveals that Covishield outperformed Covaxin

The study was carried out by a group of 11 institutes, led by scientists from the National Centre for Biological Sciences.

A vial of the Covishield vaccine. (FILE PHOTO)
Updated on Mar 08, 2024 07:26 AM IST

Learning from Covid-19 vaccination experience

The Covid-19 vaccination experience has opened a plethora of possibilities for adult vaccination

There is a consensus that Covid-19 vaccines have been successful in preventing all-cause mortality across age groups and settings (Getty Images/iStockphoto)
Published on Dec 02, 2023 12:30 AM IST

HC restrains 2 influencers from posting defamatory content against SII, Covishield

The Bombay High Court has restrained two social media influencers from posting defamatory content about Serum Institute of India, its CEO and their Covishield product in an interim application filed by SII in a defamation suit against the influencers. The court directed Yohan Tengra and Ambar Kori to remove the content from Twitter and YouTube. The SII claims the content posted by the duo about multiple deaths being due to the side effects of the vaccine was not only targeted at SII but also its CEO, and sought directions to Twitter and YouTube to take down defamatory content.

HT Image
Updated on Jun 06, 2023 01:03 AM IST

Intranasal Covid-19 vaccine sees low response on Day 1

Mumbai's rollout of the intranasal Covid-19 vaccine saw a low response on the first day with only 23 senior citizens taking the booster dose. The vaccine, iNCOVACC by Bharat Biotech, will be administered to those above the age of 60 and eligible six months after their second dose of either Covishield or Covaxin. The state health department recently procured 2 lakh doses, of which BMC procured around 2,000 doses. The vaccine will be given through spot registration at 24 centres across Mumbai.

HT Image
Updated on Apr 28, 2023 11:53 PM IST

Poor response to booster dose in Pune as vaccination resumes

PMC health officials since April 1 ran out of vaccine stock and were waiting for the vaccine supply. The civic body this week received 512 doses of the nasal vaccine iNCOVACC

The vaccination centres will be closed on Sunday and Monday. (REPRESENTATIVE PIC)
Updated on Apr 28, 2023 11:51 PM IST
ByVicky Pathare

Few takers for booster jabs as Covid-19 cases decline in Bihar

The state reported 179 fresh cases on Wednesday. The daily new cases have been declining since April 22 when the state reported the month’s highest single-day spike of 198 infections

Patna administered only 224 shots of the Corbevax vaccine since April 16 (Representative Photo)
Updated on Apr 28, 2023 08:14 PM IST

BMC to roll out intranasal Covid vaccine for senior citizens

The vaccination drive will take place in 24 centres – one in every civic ward – across the city. The vaccine will be given through spot registration and addresses of all the locations will be posted daily on BMC’S Twitter account.

HT Image
Updated on Apr 28, 2023 12:34 AM IST

Serum Institute of India to produce 5mn Covishield doses in two months

SII has made available five to six million Covovax doses even as the demand for it is still almost zero. We will produce the same amount of Covishield doses in the next two to three months, said Adar Poonawalla

Adar Poonawalla, chief executive officer of Serum Institute of India (SII). (HT PHOTO)
Updated on Apr 22, 2023 11:01 PM IST

WATCH: SII chief Adar Poonawalla on vaccine availability, current Covid strain

SII chief Adar Poonawalla on Saturday said that the current Covid strain is not severe and the company has produced five to six million doses of Covovax.

SII chief executive officer Adar Poonawalla.
Published on Apr 22, 2023 03:08 PM IST

Spike in cases prompts Maharashtra to seek 0.2mn Covid vaccine from Centre

Amidst the surge in Covid-19 cases in the state and vaccine shortage, Maharashtra government has sought 0.2 million Covid vaccine doses from the Centre

Amidst the surge in Covid-19 cases in the state and vaccine shortage, Maharashtra government has sought 0.2 million Covid vaccine doses from the Centre. (HT FILE)
Updated on Apr 14, 2023 01:48 AM IST
ByVicky Pathare

Studies show XBB.1.16 is not clinically more severe

According to government data, XBB.1.16 is driving the current Covid-19 surge across the country, with at least 50% of the genome sequenced samples testing positive for it.

According to the World Health Organisation (WHO), mutations at position 478 of the SARS-CoV-2 spike protein have been associated with decreased antibody neutralization, increased transmissibility, and pathogenicity. (REUTERS)
Updated on Apr 13, 2023 12:21 AM IST

Ludhiana hospitals run out of vaccine as Covid cases rise, last jab given on March 28

Government as well as major private hospitals across Ludhiana, including Dayanand Medical College and Hosptial (DMCH), Apollo hospital and Christian Medical College (CMC) are facing shortage of vaccine stock

As per the data from Integrated Disease Surveillance Programme (IDSP) Department of Health & Family Welfare Punjab, Ludhiana district reported 41 Covid-19 cases in March (HT File Photo)
Updated on Apr 12, 2023 11:56 PM IST
ByDinkle Popli, Ludhiana

India's Serum Institute resumes Covishield production as Covid cases surge

SII CEO Adar Poonawalla says Covishield manufacturing has resumed, 6M Covovax booster doses ready, and manufacturers are ready but no demand yet.

Adar Poonawalla, CEO of Serum Institute of India (HT FILE PHOTO)
Published on Apr 12, 2023 05:38 PM IST
PTI | | Posted by Animesh Chaturvedi

Covovax to be available on CoWIN as booster dose soon. Check details

Covovax is likely to be available on the portal in a few days at a price of ₹225 per dose plus applicable GST.

Covovax can be administered to those who have already vaccinated with Covishield or Covaxin. (AFP)
Published on Apr 10, 2023 05:00 PM IST
PTI |

Bihar’s unmet demand of vaccine goes up with Covid cases

Over 3.49 crore precautionary doses or as many people are still to take their precautionary dose among the 5.9 crore adult population in the state, said health officials.

A health official collects swab samples for Covid-19 testing in Patna on Saturday. (HT Photo)
Updated on Apr 09, 2023 10:34 PM IST

Amid Covid surge, Tricity short of vaccine doses

Since April 1, residents of Chandigarh have been unable to receive the Covid-19 vaccine as stock ended by March 31. The local health department has reached out to the Government of India for additional vaccine supplies, but there is currently no information on when the fresh stock will arrive.

Over the past week, numerous individuals have been turned away empty-handed from dispensaries and hospitals as a shortage of vaccines has left them unable to receive their much-needed jabs. (AFP)
Updated on Apr 09, 2023 02:05 AM IST
ByRobert Abraham, Chandigarh
SHARE
  • 1
  • 2
  • 3
  • ...
Story Saved
Live Score
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Tuesday, February 11, 2025
Start 14 Days Free Trial Subscribe Now
Follow Us On